PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD90.2 (Thy1.2), 25 μg
PE/Dazzle™ 594 anti-mouse CD90.2, 100 μg
PE/Dazzle™ 594 anti-mouse CD90.2, 25 μg
PE/Dazzle™ 594 anti-mouse CX3CR1, 100 μg
PE/Dazzle™ 594 anti-mouse CX3CR1, 25 μg
PE/Dazzle™ 594 anti-mouse F4/80, 100 μg
PE/Dazzle™ 594 anti-mouse F4/80, 25 μg
PE/Dazzle™ 594 anti-mouse FcεRIα, 100 μg
PE/Dazzle™ 594 anti-mouse FcεRIα, 25 μg
PE/Dazzle™ 594 anti-mouse I-A/I-E, 100 μg
PE/Dazzle™ 594 anti-mouse I-A/I-E, 25 μg
PE/Dazzle™ 594 anti-mouse Ly-6A/E (Sca-1), 100 μg
PE/Dazzle™ 594 anti-mouse Ly-6A/E (Sca-1), 25 μg
PE/Dazzle™ 594 anti-mouse Ly-6C, 100 μg
PE/Dazzle™ 594 anti-mouse Ly-6C, 25 μg
PE/Dazzle™ 594 anti-mouse Ly-6G, 100 μg